Peel Hunt reiterated their buy rating on shares of Craneware plc (LON:CRW) in a research note released on Monday. Peel Hunt currently has a GBX 1,495 ($19.83) price objective on the stock.

Separately, N+1 Singer reiterated a hold rating on shares of Craneware plc in a report on Tuesday, September 5th.

Craneware plc (LON CRW) opened at 1292.50 on Monday. Craneware plc has a 52-week low of GBX 950.00 and a 52-week high of GBX 1,885.00. The firm’s market cap is GBX 348.47 million. The company has a 50 day moving average price of GBX 1,306.96 and a 200-day moving average price of GBX 1,268.04.

ILLEGAL ACTIVITY WARNING: This news story was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at

The firm also recently announced a dividend, which will be paid on Thursday, December 7th. Shareholders of record on Thursday, November 9th will be paid a GBX 11.30 ($0.15) dividend. This represents a yield of 0.85%. This is a boost from Craneware plc’s previous dividend of $8.70. The ex-dividend date is Thursday, November 9th.

About Craneware plc

Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.

Receive News & Stock Ratings for Craneware plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware plc and related stocks with our FREE daily email newsletter.